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Abstract
Basal ganglia refers to the deep gray matter masses on the deeply telencephalon and 
encompasses a group of nuclei and it influence the information in the extrapyramidal 
system.  In human they are related with numerous significant functions controlled by the 
nervous system. Gross anatomically, it is comprised of different parts as the dorsal stria-
tum that are consisted of the caudate nucleus and putamen and ventral striatum which 
includes the nucleus accumbens, olfactory tubercle, globus pallidus, substantia nigra, and 
subthalamic nucleus. Nucleus accumbens, is also associated with reward circuits and has 
two parts; the nucleus accumbens core and the nucleus accumbens shell. Neurological 
diseases are characterized through the obvious pathology of the basal ganglia, and there 
are important findings explaining striatal neurodegeneration on human brain. Some of 
these diseases are induced by bacterial and/or viral infections. Surgical interference can 
be one alternative for neuronal disease treatment like Parkinson’s Disease or Thiamine 
Responsive Basal Ganglia Disease or Wilson’s Disease, respectively in addition to the vas-
cular or tumor surgery within this area. Extensive knowledge on the morphological basis 
of diseases of the basal ganglia along with motor, behavioral and cognitive symptoms can 
contribute significantly to the optimization of the diagnosis and later patient’s treatment.
Keywords: anatomy, biology, surgery, basal ganglia
1. Structure and function of human basal ganglia
The term “basal ganglia” refers to the deep gray matter masses on the deep telencephalon and 
encompasses a group of nuclei [1]. Generally, basal ganglia influence information in the extra-
pyramidal system and in human beings they are related with numerous significant functions 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
controlled by the nervous system, including control of the voluntary motor movements, pro-
cedural learning, and habitual behaviors such as eye movements, cognition, and emotions. 
The nuclei group is placed deep beneath the cortical area of the brain.
Additionally, the basal ganglia specialize in processing data on movement and in fine adjust-
ment of the brain circuit activity that defines the best suitable response in specific habitual 
conditions/actions such as riding a bicycle, playing a piano, and so on. They also play a major 
role while planning movement and learning novel actions in new situations [2, 3]. From an 
embryological point of view, the central nervous system (CNS) develops in early stages of 
embryological development in many of mammals, including humans, from the neural plate. 
In humans, at the middle of the third week of development, ectodermal cells from epiblast 
fold to form a neural groove and then differentiate into the neural tube. At the 24th day, the 
anterior neuropore and then at the 27th day the posterior neuropore are closed [4–6], while 
the cerebrospinal fluid is secreted by the ependymal cells, which are lining within the ven-
tricular system, prosencephalic, mesencephalic, and rhombencephalic vesicles that develop 
from the rostral part of the neural tube and also the spinal cord from the caudal part of the 
neural tube. While telencephalic vesicles developed from a part of the prosencephalic vesicle 
at the late 34th day, at the 36th day, anlage primordium of the future cerebral cortex, basal 
ganglia, and olfactory bulb can be clearly identified. At the eighth week of the development of 
the basal ganglia, neuroepithelium is clearly defined near the other epithelial structures such 
as thalamic, hippocampal, and hypothalamic epitheliums. Basal ganglia neurons are derived 
from this epithelium [4–6]. Between the 19 and 22 gestational weeks, the neuroepithelial cell 
layer becomes thicker and new neurons are generated, which migrated into the striatum. 
Between the 23 and 28 gestational weeks, in basal ganglia, the neuroepithelial cell layer over 
some places of caudate nucleus became faint. Again, at week 27 of the development in the 
basal ganglia, neuroepithelial cellularity is scant. Between the 29 and 33 gestational weeks 
in the basal ganglia, neuroepithelium was thicker over the striatum and nucleus accumbens. 
At the 32nd week of the development process, the number of the glial cells increased [4–6]. 
On the other hand, during this period, the onset of myelinization was very silent. At the 35th 
week, it can be detected microscopically in the subventricular zone, neuroepithelial cells are 
limited and the glial cell number is increased. In addition, there is a slight onset of myeliniza-
tion in the internal capsule. At term, proliferating neuroepithelial cells can be detected in the 
subventricular zone, while the numbers of astrocytes decrease in the internal capsule and 
basal ganglia. In the postnatal period, basal ganglia and diencephalic neurons were well orga-
nized, and myelinization of the internal capsule is complete approximately at the 6th week 
postnatally. Two years postnatal, in basal ganglia, all of the mature histological structures 
can be clearly detected in the caudate and putamen, and myelinization of internal capsule 
appeared completely [4–6].
In our investigation, we aimed to highlight the anatomical, biological, and surgical importance 
of cortical‐basal ganglia circuits and their role in the pathogenesis of neurological process. 
Depending on the facts available nowadays and our experience, we developed an opinion 
that detailed anatomy related information in embryology, histology, and gross anatomy as 
well as molecular and surgical information on the basal ganglia and neighborhood structures 
may cause confused clinical outcomes and possibly the option of renovating the morphologi-
cal brain structure after intervention to the region of intervention [4–6].
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Gross anatomically, the basal ganglia are composed of different parts including the dorsal 
striatum consisting the caudate nucleus and putamen and ventral striatum, which includes 
the nucleus accumbens, olfactory tubercle, globus pallidus, substantia nigra, and subtha-
lamic nucleus. Each of these parts possesses defined, complex internal morphological and 
biological features. Basal ganglia are composed of several subcortical nucleus groups that 
are located deep on each of the cerebral hemispheres. They are called “lentiform nucleus,” 
which includes both the putamen and globus pallidus; the “striatum,” which includes the 
nucleus caudatus and putamen; and “corpus striatum,” including the caudate nucleus and 
the nucleus lentiformis, and the others including the claustrum, subthalamic nucleus, nucleus 
accumbens, and their projections. The substania nigra is also a basal nucleus, which is placed 
on the mesencephalon [4–6]. This nuclear group carries heterogeneous formations, function-
ally, terminologically and phylogenetically. Details are presented in Figure 1.
According to the previous classification, the amygdaloid body was considered to be a part of 
the basal ganglia (archistriatum). Due to the acquisition of new scientific data associated with 
it, anatomists considered it as a functional educative part [8].
Clastrum is located on the lateral to the putamen and medial to the insula, which was noted 
by some sources to be a part of the basal ganglia [8]. The globus pallidus externus was origi-
nally revealed as a simple relay within the basal ganglia [9].
The nucleus accumbens is also associated with reward circuits that are located in the basal 
forebrain region superior to the preoptic region of the hypothalamus, while the prefrontal area 
was on both cerebral hemispheres, whose mission is planning and motivating movement per-
formed by the body. The nucleus accumbens has two parts: the nucleus accumbens core and 
the nucleus accumbens shell, which consist of their own morphology and functions [10–15].
Figure 1. Nuclei of the basal ganglia showing the different components [7], with modifications.
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From the histophysiological point of view, basal ganglia circuits contain an assortment of 
cell types that mediate synaptic interactions within and between basal ganglia nuclei [16]. 
Neurotransmitters also play an important role in the different areas of the basal ganglia. For 
example, dopamine, which has a very important function within the basal ganglia, is the 
source of the striatal input in the substantia nigra (Figure 2).
2. Pathogenic conditions of the basal ganglia
Huntington’ and Parkinson's diseases are caused by the degeneration of dopamine‐ producing 
cells in the substantia nigra [4, 17]. On the other hand, most of the neurons in the basal ganglia 
use gamma‐Aminobutyric acid (GABA) as a neurotransmitter, which possesses an inhibitory 
effect on the target neurons. Acetylcholine is another important neurotransmitter and is regu-
larly used by both external inputs to the striatum and by a group of striatal neurons. Although 
the total number of cholinergic neurons is the smallest in all brain neurons, one of the major 
acetylcholine concentration regions is the striatum [4, 17].
Striatum (Figures 3 and 4) is currently considered to be the largest region of the basal ganglia 
that arise from numerous large and small bundles of nerve fibers [18]. The histological orga-
nization of the striatum is considered very complex. The great populations of striatal neurons 
Figure 2. Illustrations showing the substancia nigra, according to [8] with modifications.
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Figure 3. Corpus striatum in the sagittal section stained with caspase 3 immunostaining. Magnification, ×2 (with 
courtesy to Esra ASLAN MD).
Figure 4. Corpus striatum in the coronal section with thyrosine hydroxylase immunostaining. Magnification, ×10. (with 
courtesy to Esra ASLAN, MD, Afyon Kocatepe University).
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are medium spiny neurons, which are GABAergic cells with small bodies, densely covered 
dendritic spines that receive input from the cortex and the thalamus. The cholinergic neuron 
population in striatum comprises of the cholinergic neurons with smooth dendrites [2].
The pallidum consists of both the globus pallidus and the ventral pallidum. The glo-
bus pallidus can be divided functionally into the internal and external segments. 
Histologically, both segments have primarily GABAergic neurons [19]. While external 
segments receive inputs mainly from the striatum and pass through the subthalamic 
nucleus, the internal segment receives input from direct and indirect pathways. Pallidal 
neurons functions basically via de‐inhibition, a mechanism in which there are inhibitory 
effects on the target [2].
The substantia nigra is a mesencephalic gray matter portion of the basal ganglia, which is 
divided into two parts: pars compacta and pars reticulate. Although pars compacta produces 
dopamine, which plays a major role as a regulator neurotransmitter in the striatal pathway, 
the pars reticulate has inhibitory effects on the thalamus [19].
The subthalamic nucleus is a diencephalic gray matter portion of the basal ganglia and pro-
duces glutamate, which is an excitatory neurotransmitter in the ganglia. This nucleus, while 
receiving inhibitory input from external part of the globus pallidus, also sends excitatory 
input to the internal part of the globus pallidus.
3. Basal ganglia‐related pathological conditions
Clinically, many neurological diseases are characterized through the obvious pathology of the 
basal ganglia, and there are important findings that explain striatal neurodegeneration on the 
human brain. Some of these diseases are induced by bacterial and/or viral infections where 
the bacteria and/or virus introduces some genetic material and, as a consequence, either acti-
vated or downregulated some of the life's essential processes [20–26] or other diseases that are 
affected by the cytokine regulation in association with neurodegenerative diseases like TGF‐β 
[27] or TNF‐α [28] in addition to applications related to medical solutions like in dentistry [29]. 
Here, and as a consequence, affecting either the functionality or the neuronal structure or both 
of them can be seriously affected. Lately, more knowledge about the problems of the basal 
ganglia patients with neurodegenerative, vascular, metabolic, inflammatory, immunologic, 
allergic, congenital, traumatic, endocrine, malignant, and neurophyschiatric diseases became 
available [30–32]. A comprehensive understanding of the striatal projection loss while receiv-
ing striatal input/output on the neurons will contribute to the available knowledge related to 
the pathogenesis of the neurological diseases. Surgical interference can also be one alternative 
for neuronal disease treatment as it is the case for Parkinson’s disease, thiamine responsive 
basal ganglia disease or Wilson's disease, respectively, in addition to the vascular or tumor 
surgery within this area. The lesions of the basal ganglia can cause tremors, grimaces, and 
repetitive movements [4, 17]. At the same time, in different pathological processes, such as 
Kernicterus, Tourette syndrome, hemiballismus, obsessive‐compulsive disorder, neonatal and 
lacunar infarction, Huntington's and Parkinson's diseases, basal ganglia neurons were affected. 
Again, in carbon monoxide poisoning, selective necrosis is caused in the globus palidus [3, 33].
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4. Potential approaches for basal ganglia disease treatment
In order to limit or inhibit this type of disorders, gene therapeutic [34] based treatment modali-
ties bear potential for the treatment of nervous system diseases or disorders, these include viral 
vector systems [35, 36], gene‐based vaccines and immunotherapy [37, 38], plasmid DNA appli-
cations [39], cytokine targeting like TNF‐α targeting [28], epigenetic targeting [40] and anti ner-
vous system degenerative diseases treatment by molecular regulators RNAi applications [41]. 
Several studies on basal ganglia supported by data aligned to age‐ and/or gender‐ dependent 
relation of intelligence with volumes of the nuclei were presented recently [42, 43], still limited 
results were known regarding the potential influence of age‐ and sexual distinctive diseases on 
the subcortical nuclei [44]. The basal ganglia (BG), which play a major role in selecting and shap-
ing motor and cognitive behaviors, are significant for connection among forebrain nuclei [9].
Surgically, in some neurologic diseases, using deep brain stimulation (DBS), which is an 
implanted electrical device modulate for distinct targets at the brain, resulted in the symptomatic 
improvement of movement disorder, especially [45, 46] in both hyper‐ and hypokinetic move-
ment disorders of the basal ganglia deep brain stimulation (DBS) that is considered highly effec-
tive. The clinical benefit of DBS is based on the experience with prior surgical ablative therapies 
for the disorders of these regions, and, in part, used by neurosurgeons decades ago. The most 
commonly DBS‐treated conditions were and are Parkinson’s disease and dystonia, which are 
treated by electrical or radiofrequency lesioning of that region before DBS [46–53]. The duration 
and temperature are important for both procedures. Applying electrical current the functions 
that were partially or totally lost due to nervous system disease or injury can be restored [54].
In stereotaxic surgery, some entry points described by the authors for nucleus accumbens [55] 
were as follows: 7–9 mm below the anterior commissure‐posterior commissure (AC‐PC) line, 
19–23 mm prior to the midpoint, and 4–10 mm lateral to the median line. The original target 
is the core of the nucleus accumbens. For deep brain stimulation applications as refractory 
major depression, Tourette syndrome and obsessive‐compulsive disorders the stereotactic 
coordinates were as follows: 4–4.5 mm ventral to the AC‐PC plane, 1.5–2.5 mm anterior to the 
anterior border of the AC, and 6.5–8 mm lateral to the midline [56, 57].
In treating obsessive‐compulsive disorders with accompanying major depression, Aouizerate 
et al. reported their experience in DBS targeting as the tips of the electrodes were situated 
3.0 mm below the AC‐PC line, 8.9 mm lateral to the AC‐PC line, and 36.5 mm anterior to the 
PC on the right side, and 1.7 mm below and 7.6 mm lateral to the AC‐PC line and 31.4 mm 
anterior to the PC on the left side [58].
The subthalamic nucleus (STN) of advanced Parkinson’s disease patients undergoing deep 
brain stimulation application is a prominent target for treatment. In many patients, to identify 
significant target, microelectrode recording (MER) is used. Moran in a previous work showed 
that trajectories served as a training set and found the error in predicting the STN entry to be 
(mean ± SD) 0.18 ± 0.84, and 0.50 ± 0.59 mm for the STN exit point, which yields a 0.30 ± 0.28 mm 
deviation from the expert’s target center by using MER [59]. In the correlation analysis, there 
was a negative correlation between right substancia nigra (SN) volume and unified Parkinson 
disease rating scale (UPDRS) score (r = −0.466, p = 0.038) and there was a tendency but not a 
significant correlation between the left SN volume and UPDRS score (r = −0.443, p = 0.050).
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In a previous approach, it was shown that subjects suffering from Parkinson's disease showed 
a significant asymmetry between both the left and right SN, nucleus caudatus, and nucleus 
lentiformis volumes (p = 0.001, p < 0.001, p = 0.044), with taking into account that the  control 
subjects also showed a significant asymmetry between the volumes of left and right SN, 
nucleus caudatus, and nucleus lentiformis (p < 0.001, p = 0.003, p < 0.001, respectively). Mean 
volume values for SN, nucleus caudatus, and nucleus lentiformis are shown in Table 1 [60].
Further, in the same approach, the group was examined after subgrouping according to 
 gender into male and female subgroups, as seen in Table 2.
In addition, during our experience using stereological methods on the basal ganglia volumetry on 
the right‐handed patients with the Parkinson's disease, we found that the left basal ganglia struc-
ture was smaller than left ones. However, when we compared them with the control cases, only 
substantia nigra possessed a smaller volume. Also, evaluation of the basal ganglia and substantia 
nigra volume in Parkinson's disease (PD) patients revealed a significant atrophy in SN in com-
parison to the healthy age‐matched control subjects. However, significant atrophy in nucleus len-
tiformis and nucleus caudatus was not found during the study. Basal ganglia and the SN are the 
regions with predominantly pathological changes in PD [61]. There are studies in the literature 
that examine the volumetric differences in basal ganglia and SN anatomy in PD; however, there 
is no study to our knowledge in the literature that evaluates the asymmetrical volume changes 
by using the stereological technique [62, 63]. Cavalieri’s principle of stereological approaches 
through point counting is accomplished by overlying each selected section using a regular grid of 
test points that is randomly positioned [64]. The Cavalieri theorem of systematic sampling com-
bined with point counting proved to be a reliable, simple, inexpensive, and efficient method for 
volume estimation in MRI [65], and this stereological approach can provide valuable information 
during the morphological changes evaluated during Parkinson's disease development.
Surgical procedures applied for this purpose can be variable. Gallina et al. [66] provided 
details of the surgical procedure for both caudate and putaminal tracks through a single 
frontal entry point for six patients, and for the following 10 procedures and they used two 
completely distinct routes, with two separate entry points, each for the nucleus caudatus and 
putamen, respectively.
Parkinson patients Controls P value
Mean ± SD Mean ± SD
SN left 0.67 ± 0.16 0.78 ± 0.13 0.026
SN right 0.75 ± 0.17 0.92 ± 0.18 0.005
NC left 4.49 ± 0.50 4.42 ± 0.24 0.602
NC right 4.47 ± 0.54 4.60 ± 0.21 0.632
NL left 5.29 ± 0.57 5.25 ± 0.53 0.832
NL right 5.40 ± 0.54 5.52 ± 0.52 0.473
Table 1. Standard volumes of the substantia nigra, nucleus caudatus, and nucleus lentiformis and a group of Parkinson's 
disease patients compared to subjects of a healthy control group [59].
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In surgical processes, surgeons use a stereotactic frame that helps to ensure optimal position-
ing of desired targets, or frameless stereotactic systems [67] or, alternatively, neuronaviga-
tion or electrophysiological mapping of the brain for lesioning‐related basal ganglia and for 
obtaining the main target in a three‐dimensional manner in addition to protect the surround-
ing neural tissue [53, 55, 57, 68, 69].
5. Conclusion
Extensive knowledge on the morphological basis of diseases of the basal ganglia along with 
motor, behavioral, and cognitive symptoms may significantly contribute to the optimization of 
both the diagnosis (especially anatomical and histological) and later treatment of the patients, 
especially patients suffering from neurodegenerative, vascular, metabolic, inflammatory, 
immunologic, allergic, congenital, traumatic, endocrine, malignant, and neurophyschiatric 
diseases, in order to at least delay the breakout or the pathogenic degenerative process related 
to the their disease and/or improve the life quality of the patients. Experimental set‐ups deal-
ing with this level of problems can provide us the necessary information for the treatment 
modalities applied in human therapy. Gene therapeutic approaches can be a future effective 
alternative for these classes of disease treatment.
Parkinson disease Control
Mean ± SD Mean ± SD
Left side Right side P value Left side Right side P value
Male
Substancia nigra n = 13 n = 13 0.005 n = 10 n = 10 0.001
0.69 ± 0.14 0.75 ± 0.16 0.77 ± 0.15 0.91 ± 0.16
Nucleus caudatus n = 13 n = 13 0.007 n = 10 n = 10 0.001
4.56 ± 0.51 4.72 ± 0.60 4.40 ± 0.23 4.58 ± 0.25
Nucleus lentiformis n = 13 n = 13 0.515 n = 10 n = 10 0.001
5.29±0.65 5.37 ± 0.57 5.24 ± 0.54 5.56 ± 0.44
Female
Substancia nigra n = 7 n = 7 0.020 n = 10 n = 10 0.008
0.63 ± 0.20 0.75 ± 0.2 0.77 ± 0.15 0.91 ± 0.16
Nucleus caudatus n = 7 n = 7 0.014 n = 10 n = 10 0.039
4.36 ± 0.5 4.57 ± 0.45 4.40 ± 0.23 4.58 ± 0.25
Nucleus lentiformis n = 7 n = 7 0.092 n = 10 n = 10 0.001
5.28 ± 0.43 5.45 ± 0.52 5.24 ± 0.54 5.56 ± 0.44
Table 2. Substancia nigra, nucleus caudatus, and nucleus lentiformis volumes in male and female groups of Parkinson 
disease patients [60].
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